Julie Beshai

Director, Pharmaceutical Sector and Market Access

Julie is a seasoned professional with over a decade of experience in the pharmaceutical and biotechnology industries. Passionate about oncology and the treatment of rare diseases, she stays on top of scientific and medical breakthroughs. She develops effective strategies for market access to innovative treatments and excels at implementing highly targeted initiatives. Julie has cultivated deep expertise in facilitating access to cutting-edge therapies that bring hope and an improved quality of life to thousands of patients in need.

Julie understands the realities of pharmaceutical companies and has an in-depth grasp of the industry’s complex dynamics, having served as a leader in managing global product portfolios. Her expertise encompasses a comprehensive evaluation of market access, including business development and pre- and post-commercialization strategies. She is recognized for her ability to craft tailored submissions that meet reimbursement criteria in Canada and has successfully led multiple dossiers submitted to health technology assessment bodies (CADTH, INESSS).

She has also implemented negotiation strategies with the pan-Canadian Pharmaceutical Alliance (pCPA), provincial public payers, and private insurers. Julie is well-versed in pricing strategies, adeptly navigating the nuances of various provincial regulations, optimizing competitive list prices, and ensuring compliance with PMPRB regulations.

Julie holds an MBA in Pharmaceutical Management and a B.Sc. in Biochemistry.